日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

HFB301001, an OX40-based immunotherapy, drives Treg clearance and CTL activation through optimized OX40 receptor clustering.

HFB301001 是一种基于 OX40 的免疫疗法,通过优化 OX40 受体聚集来驱动 Treg 清除和 CTL 活化。

Zhao Jiliang, Zhang Dongping, Lu Yun-Yueh, Jin Ruina, Li Fan, Zhang Zhaoyuan, Ni Wentao, Gong Nanxin, Wang Yi, Yin Zhongqian, Du Yazhuo, Ma Wenxuan, Wang Xiaoqian, Zu Lingling, Liu Shiyu, Yang Kailu, Bai Yiyang, Gan Jinping, Adrian Francisco, Hong Zhangyong, Zhang Sihe, Chang Yunsong, Wang Zhenyu, Jin Xin, Zhong Jianguo, Ge Kunkun, Peng Sibo, Ding Dan, Zheng Wei, Xu Song, Wang Wei, Schweizer Liang, Zhang Hongkai

Effect of virtual reality intervention on hospitalized patients with acute pain after thoracoscopic surgery: a pilot randomized clinical trial

虚拟现实干预对胸腔镜手术后急性疼痛住院患者的影响:一项初步随机临床试验

Cao, Weibo; Ren, Fan; Li, Tong; Ma, Fei; Shi, Yuan; Li, Xuanguang; Cao, Cancan; Zhou, Ning; Li, Hanyi; Yu, Haochuan; Mao, Fuling; Chen, Gang; Zu, Lingling; Wei, Li; Li, Qing; Zhang, Yuanyuan; Su, Lin; Cui, Wei; Wu, Li; Zheng, Yuxin; Li, Jing; Wang, Chunyan; Ju, Renhua; Fang, Chongliang; Yin, Ling; Lu, Yi; Zhang, Qiang; Xu, Song

Assessment of NUDT5 in Endometrial Carcinoma: Functional Insights, Prognostic and Therapeutic Implications.

子宫内膜癌中 NUDT5 的评估:功能见解、预后和治疗意义

Yu Hongfei, Zu Lingling, Zang Yuqin, Teng Fei, Wang Tao, Wu Ming, Wang Yingmei, Xue Fengxia

[FCN3 Can Serve as A Potential Biomarker for Prognosis and 
Immunotherapy of Lung Squamous Cell Carcinoma]

[FCN3可作为肺鳞状细胞癌预后和免疫治疗的潜在生物标志物]

Li, Wei; Zu, Lingling; Xu, Song

Constructing a folate metabolism gene signature for predicting prognosis in pulmonary neuroendocrine carcinomas.

构建叶酸代谢基因特征以预测肺神经内分泌癌的预后

Tang Quanying, Li Luoyi, Wang Ruiyao, Jin Xin, Jia Xuewang, Zhu Yifan, Sun Xiaoyue, Zhong Jianguo, Xie Huangsheng, Da Yurong, Zu Lingling, Xu Song

The nomogram for the prediction of overall survival after surgery in patients in early-stage NSCLC based on SEER database and external validation cohort

基于SEER数据库和外部验证队列的早期非小细胞肺癌患者术后总生存期预测列线图

Zhang, Hao; Zeng, Jingtong; Li, Xianjie; Zhang, Bo; Wang, Hanqing; Tang, Quanying; Zhang, Yifan; Bao, Shihao; Zu, Lingling; Xu, Xiaohong; Xu, Song; Song, Zuoqing

PD‑1/PD‑L1 immune checkpoint inhibitors in neoadjuvant therapy for solid tumors (Review)

PD-1/PD-L1免疫检查点抑制剂在实体瘤新辅助治疗中的应用(综述)

Tang, Quanying; Zhao, Shikang; Zhou, Ning; He, Jinling; Zu, Lingling; Liu, Tingwen; Song, Zuoqing; Chen, Jun; Peng, Ling; Xu, Song

A Review of Biomarkers and Their Clinical Impact in Resected Early-Stage Non-Small-Cell Lung Cancer

早期非小细胞肺癌切除术后生物标志物及其临床意义综述

Cao, Weibo; Tang, Quanying; Zeng, Jingtong; Jin, Xin; Zu, Lingling; Xu, Song

Correction: Wilms' tumour gene 1 (WT1) enhances non-small cell lung cancer malignancy and is inhibited by microRNA-498-5p

更正:Wilms肿瘤基因1 (WT1) 可增强非小细胞肺癌的恶性程度,并受microRNA-498-5p抑制。

Li, Xuebing; An, Wenzhe; Pan, Hongli; Fan, Yaguang; Huang, Hua; Wang, Yixuan; Shen, Wang; Zu, Lingling; Meng, Fanrong; Zhou, Xuexia

Clinical significance of preoperative neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in the prognosis of resected early-stage patients with non-small cell lung cancer: A meta-analysis

术前中性粒细胞-淋巴细胞比值和血小板-淋巴细胞比值在非小细胞肺癌早期切除患者预后中的临床意义:一项荟萃分析

Cao, Weibo; Yu, Haochuan; Zhu, Shuai; Lei, Xi; Li, Tong; Ren, Fan; Zhou, Ning; Tang, Quanying; Zu, Lingling; Xu, Song